Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, Biomaterials, 3(34), p. 735-745, 2013

DOI: 10.1016/j.biomaterials.2012.10.016

Links

Tools

Export citation

Search in Google Scholar

Incorporation of stromal cell-derived factor-1α in PCL/gelatin electrospun membranes for guided bone regeneration

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

The goal of this work was to evaluate the effect of membrane functionalization with a chemotactic factor on cell recruitment and bone formation in order to develop a bioactive membrane for guided bone regeneration (GBR) applications. To this end, GBR membranes were prepared by electrospinning using poly(ε-caprolactone) (PCL) blended with type B-gelatin, and functionalized with stromal cell derived factor-1α (SDF-1α) via physical adsorption. Firstly, the obtained membranes were evaluated in vitro for SDF-1α release and chemotactic effect on bone marrow stromal cells (BMSCs). Subsequently, in vivo BMSCs recruitment and bone regeneration in response to SDF-1α loaded PCL/gelatin electrospun membranes were assessed in rat cranial defects. The results showed that PCL/gelatin electrospun membranes provided a diffusion-controlled SDF-1α release profile. Furthermore, the membranes loaded with different amounts of SDF-1α (50-400 ng) significantly induced stimulated chemotactic migration of BMSCs in vitro without dose-dependent effects. Eight weeks after implantation in rat cranial defects, SDF-1α loaded membranes yielded a 6-fold increase in the amount of bone formation compared to the bare membranes, albeit that contribution of in vivo BMSCs recruitment to the bone regeneration could not be ascertained. In conclusion, the results of current study indicate the potential for using SDF-1α loaded PCL/gelatin electrospun membrane as a bioactive membrane, which is beneficial for optimizing clinical application of GBR strategies. ; status: published